CBSA and Hogan Lovells bring you 2021’s Regulatory Symposium in four virtual sessions every Thursday from 9:00—10:00am MT starting in July.

Topics include:

• July 15: Employment Issues and Returning to Work – Including Mandatory Vaccinations
  Speakers: Michael E. DeLarco, Office Managing Partner (New York), Hogan Lovells, and Eleanor deGolian Kasper, Associate (Colorado Springs), Hogan Lovells
• July 22: The Future of Litigation – Prep Act, Government Authorizations, and Liability
  Speakers: Michael C. Theis, Partner (Denver), Hogan Lovells, and Emily Lyons, Senior Associate (Washington, D.C.), Hogan Lovells
• July 29: FDA Emergency Use Authorization and the Transition Back to Normal Health Approvals – A Look at the Next 9-18 Months (End of Public Health Declaration)
  Speakers: Jodi Scott, Partner (Denver), Hogan Lovells and Wil Henderson, Senior Associate (Denver), Hogan Lovells
• August 5: Digital Health and its Evolution Since the Beginning of COVID-19
  Speakers: Brooke Bumpers, Counsel (Washington, D.C.), Hogan Lovells and Lowell Zeta, Counsel (Washington, D.C.), Hogan Lovells and TBA

Complete Four-Session Series: Complimentary to CBSA Members/$25 Non Members
Please select all sessions you wish to attend on the registration page.

Session Details

July 22: The Future of Litigation – Prep Act, Government Authorizations, and Liability
Speakers: Michael C. Theis, Partner (Denver), Hogan Lovells, and Emily Lyons, Senior Associate (Washington, D.C.), Hogan Lovells

This presentation will focus on investigation and litigation risks in the post-pandemic world.  Through the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), the Paycheck Protection Program (PPP) and related emergency stimulus legislation, the federal government provided massive infusions of cash into the private and public sectors. Individuals and entities had to make a variety of representations and certifications to the government to establish eligibility and, in some cases, to describe how the funds were used.  Knowingly making false claims on these programs comes with risks for civil liability and penalties under the False Claims Act (FCA). Pursuing such cases is a high priority for the Department of Justice, and historically, the Department has ramped up investigations and prosecutions in periods of increased government spending in the wake of natural and man-made crises. The CARES Act itself created a new inspectors general office—the Office of the Special Inspector General for Pandemic Recovery—that is specifically tasked with the duty to conduct investigations of loans, loan guarantees, and other investments under the Act.  We will address the risks presented under these programs, and discuss the investigation and prosecution priorities of the Department of Justice in the Covid-19 economy, including telehealth, data privacy, and compliance with the Food Drug and Cosmetic Act.  The presentation will also discuss the emergency public health declaration providing targeted immunity liability under the Public Readiness and Emergency Preparedness Act (PREP Act) for the COVID-19 pandemic.